SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Mar-22 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Mar-22 | Grant | 24,700 | -- | -- | 130% 19.0K to 43.7K | |
05-Oct-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Oct-21 | Option Exercise | 50,000 | $0.92 | $46,000.00 | 263% 19.0K to 69.0K | |
05-Oct-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Oct-21 | Market Option Sale (Planned) | 50,000 | $4.89 | $244,500.00 | (72%) 69.0K to 19.0K | |
22-Sep-21 10:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 20-Sep-21 | Option Exercise | 25,000 | $0.92 | $23,000.00 | 132% 19.0K to 44.0K | |
22-Sep-21 10:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 20-Sep-21 | Market Option Sale (Planned) | 25,000 | $4.97 | $124,250.00 | (57%) 44.0K to 19.0K | |
01-Mar-21 7:08 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Feb-21 | Grant | 19,000 | -- | -- | 100% 0 to 19.0K |